PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $44,433 | +5.1% | 1,453 | 0.0% | 0.00% | – |
| Q1 2024 | $42,268 | +5.6% | 1,453 | 0.0% | 0.00% | – |
| Q4 2023 | $40,045 | +23.0% | 1,453 | 0.0% | 0.00% | – |
| Q3 2023 | $32,562 | -45.9% | 1,453 | -1.8% | 0.00% | – |
| Q2 2023 | $60,192 | -14.5% | 1,480 | +1.9% | 0.00% | – |
| Q1 2023 | $70,383 | +26.9% | 1,453 | 0.0% | 0.00% | – |
| Q4 2022 | $55,461 | -24.0% | 1,453 | 0.0% | 0.00% | – |
| Q3 2022 | $73,000 | +25.9% | 1,453 | 0.0% | 0.00% | – |
| Q2 2022 | $58,000 | +7.4% | 1,453 | 0.0% | 0.00% | – |
| Q1 2022 | $54,000 | -6.9% | 1,453 | 0.0% | 0.00% | – |
| Q4 2021 | $58,000 | +7.4% | 1,453 | 0.0% | 0.00% | – |
| Q3 2021 | $54,000 | -11.5% | 1,453 | 0.0% | 0.00% | – |
| Q2 2021 | $61,000 | -11.6% | 1,453 | 0.0% | 0.00% | – |
| Q1 2021 | $69,000 | -22.5% | 1,453 | 0.0% | 0.00% | – |
| Q4 2020 | $89,000 | – | 1,453 | +3532.5% | 0.00% | – |
| Q2 2016 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
| Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
| RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
| GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
| Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
| SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
| SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
| SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
| Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
| Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |